Stemirna Therapeutics
PrivateLast Round
Series D
May 25, 2023
Est. Valuation
$308.9M
Total Funding Raised
$238.5M
Company Overview
Stemirna Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for infectious diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stemirna Therapeutics Comparables
Compare Stemirna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai RNACure Biopharma Co., Ltd. | 87% | |
| Abogen Biosciences | 86% | |
| WestGene Biopharma | 86% |
Stemirna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 25, 2023 | ||||
| Strategic | Aug 27, 2021 | ||||
| Series C | Jun 1, 2021 | ||||
| Series B | Dec 1, 2020 | ||||
| Series A Extension | Feb 7, 2020 | ||||
Series A | Jul 1, 2019 |
Stemirna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 招银国际金融有限公司 | Series C |
| Shanghai Zhangjiang Torch Venture Capital | Series A |
| Greenwoods Investments | Series C |
| OrbiMed | Series C |
| Forebright Capital | Series C |
| Advantech Capital | Series C |
| CITIC Securities Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
$188M round led by Greenwoods Investments and WuXi AppTec.
- Feb 7, 2020
$4.3M round with participation from LC Ventures
Stemirna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stemirna Therapeutics's valuation, stock price, and market status.
Is Stemirna Therapeutics a public or private company?
Stemirna Therapeutics is a private company.
What is the current stock price of Stemirna Therapeutics?
Stemirna Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Stemirna Therapeutics worth (valuation)?
Stemirna Therapeutics's valuation is estimated at $308.9M based on funding round data.
Can I buy Stemirna Therapeutics stock?
Stemirna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Stemirna Therapeutics's last funding round?
Stemirna Therapeutics's most recent funding round was Series D on August 27, 2021.
Who are the main investors in Stemirna Therapeutics?
Key investors in Stemirna Therapeutics include Greenwoods Investments, HongShan.
Will Stemirna Therapeutics IPO soon?
No public IPO plans have been announced for Stemirna Therapeutics.
How can I track Stemirna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stemirna Therapeutics's secondary market activity and sign up for updates.